ArticleNature biotechnology2021
Ready-to-use public infrastructure for global SARS-CoV-2 monitoring.
Article in Nature biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Evaluating open LLMs for agentic analysis orchestration in a typical biomedical lab.bioRxiv : the preprint server for biology · 2026Article
- Ten common misconceptions about Galaxy (and why they are wrong!).PLoS computational biology · 2026Article
- Microbiology Galaxy Lab: The first community-driven gateway for reproducible and FAIR analysis of microbial data.bioRxiv : the preprint server for biology · 2025Article
- WorkflowHub: a registry for computational workflows.Scientific data · 2025Article
- PathoGFAIR: a collection of FAIR and adaptable (meta)genomics workflows for (foodborne) pathogens detection and tracking.GigaScience · 2025Article
- Positive selection, genetic recombination, and intra-host evolution in novel equine coronavirus genomes and other members of theMicrobiology spectrum · 2024Article
- Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows.Viruses · 2024Article
- Article
- The Planemo toolkit for developing, deploying, and executing scientific data analyses in Galaxy and beyond.Genome research · 2023Article
- Sierra SARS-CoV-2 sequence and antiviral resistance analysis program.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022Article
- The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update.Nucleic acids research · 2022Article
- Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City.Nature communications · 2022Article
- EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts.Bioinformatics (Oxford, England) · 2022Article
- Design of SARS-CoV-2 Variant-Specific PCR Assays Considering Regional and Temporal Characteristics.Applied and environmental microbiology · 2022Article
- Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function.Molecular biology and evolution · 2022Article
- External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories.Journal of clinical microbiology · 2022Article
- Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function.bioRxiv : the preprint server for biology · 2022Article
- Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages.Computational and structural biotechnology journal · 2022Article
- Stepwise Evolution and Exceptional Conservation of ORF1a/b Overlap in Coronaviruses.Molecular biology and evolution · 2021Article
- VirusLab: A Tool for Customized SARS-CoV-2 Data Analysis.Biotech (Basel (Switzerland)) · 2021Article
Corrections and comments
- Update of
Authors and funding
17 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.